Safety and efficacy of bimekizumab through 2 years in patients with moderate to severe plaque psoriasis: Long-term results from BE SURE randomised controlled trial and BE BRIGHT open-label extension Meeting Abstract

Industry Collaboration International Collaboration

author list

  • Thaci, Diamant; Vender, Ronald; de Rie, Menno; Conrad, Curdin; Pariser, David; Strober, Bruce; Vanvoorden, Veerle; Peterson, Luke; Madden, Cynthia; De Cuyper, Dirk; Rubel, Diana; Kimball, Alexa

publication date

  • May 1, 2022


published in


start page

  • 14

end page

  • 15


  • 63